Influence
August 7, 2024

Impact of interhospital transfer on patients with Alzheimer’s disease and other related dementias

Kathleen Unroe, M.D.

Published in the journal Alzheimer’s and Dementia. Here is a link to the article.

Regenstrief Institute authors: Kathleen Unroe M.D., MHA, Malaz Boustani, M.D., MPH

This retrospective study examined the outcomes of interhospital transfers in older adults (≥65 years), comparing those with and without Alzheimer’s disease and related dementias (ADRD). Researchers reviewed medical records to assess care utilization and outcomes following emergency department transfers to tertiary hospitals.

Findings revealed that patients with ADRD were less likely to receive intensive care or undergo procedures within 48 hours of transfer (OR 1.87; 95% CI, 1.22–2.88). They were also less likely to be admitted as full code or discharged home. While they more frequently received geriatrics and palliative care consults, the benefit of transfer for this population remains unclear.

Overall, older adults with ADRD experienced fewer high-intensity interventions after transfer, raising questions about the value and appropriateness of such transfers. Further research is needed to evaluate patient-centered outcomes and guide care decisions for this vulnerable group.

Authors

Nancy Glober1, Alexandra LaShell1, Nicholas Montelauro1, Lindsay Troyer1, Michael Supples2, Kathleen Unroe1, Christopher Tainter3, Greg Faris1, Mikita Fuchita4, Malaz Boustani1

Author Affiliations

1Indiana University School of Medicine Indianapolis Indiana USA.

2Department of Emergency Medicine Wake Forest School of Medicine Winston-Salem North Carolina USA.

3University of California at San Diego La Jolla California USA.

4University of Colorado Hospital Aurora Colorado USA.

Related News

infographic showing findings of study

Examining how insurance coverage shapes access to kidney transplantation

Regenstrief researchers contribute to a national study highlighting differences between Medicare Advantage and traditional Medicare  For people with kidney

Tarik Yuce, MD, Jiang Bian, PhD, Serena Guo, MD, PhD, Xing He, PhD, Yu Huang, PhD

GLP-1 medications linked to greater loss of regained weight after bariatric surgery

Study involving Regenstrief researchers uses real-world evidence to evaluate an option for managing weight recurrence  People who regain weight

image of a doctor consulting with a patient

Scalable approach could improve early detection of cognitive impairment in primary care

Regenstrief-led study evaluates how existing health data and patient-reported information could help clinicians identify individuals who need further assessmentEarly

Christopher Callahan, MD

Regenstrief Institute scientist named next president and CEO of Regenstrief Foundation 

Longtime Regenstrief investigator and former IU Center for Aging Research director will assume Foundation leadership in summer 2027.  Christopher